Phibro Animal Health Stock Current Valuation
| PB8 Stock | EUR 19.60 0.40 2.00% |
Valuation analysis of Phibro Animal Health helps investors to measure Phibro Animal's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Phibro Animal's price fluctuation is not too volatile at this time. Calculation of the real value of Phibro Animal Health is based on 3 months time horizon. Increasing Phibro Animal's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Phibro stock is determined by what a typical buyer is willing to pay for full or partial control of Phibro Animal Health. Since Phibro Animal is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Phibro Stock. However, Phibro Animal's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 19.6 | Real 17.32 | Hype 19.6 |
The real value of Phibro Stock, also known as its intrinsic value, is the underlying worth of Phibro Animal Health Company, which is reflected in its stock price. It is based on Phibro Animal's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Phibro Animal's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Phibro Animal Health helps investors to forecast how Phibro stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Phibro Animal more accurately as focusing exclusively on Phibro Animal's fundamentals will not take into account other important factors: Phibro Animal Health Company Current Valuation Analysis
Phibro Animal's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Phibro Animal Current Valuation | 977.72 M |
Most of Phibro Animal's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Phibro Animal Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Phibro Animal Health has a Current Valuation of 977.72 M. This is 93.19% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all Germany stocks is 94.12% higher than that of the company.
Phibro Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Phibro Animal's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Phibro Animal could also be used in its relative valuation, which is a method of valuing Phibro Animal by comparing valuation metrics of similar companies.Phibro Animal is currently under evaluation in current valuation category among its peers.
Phibro Fundamentals
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0532 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 977.72 M | |||
| Shares Outstanding | 20.34 M | |||
| Shares Owned By Insiders | 0.54 % | |||
| Shares Owned By Institutions | 99.46 % | |||
| Price To Earning | 21.51 X | |||
| Price To Book | 2.32 X | |||
| Price To Sales | 0.52 X | |||
| Revenue | 942.26 M | |||
| Gross Profit | 285.72 M | |||
| EBITDA | 117.13 M | |||
| Net Income | 49.17 M | |||
| Cash And Equivalents | 93.21 M | |||
| Cash Per Share | 2.30 X | |||
| Total Debt | 417.93 M | |||
| Debt To Equity | 1.80 % | |||
| Current Ratio | 3.04 X | |||
| Book Value Per Share | 6.63 X | |||
| Cash Flow From Operations | 31.65 M | |||
| Earnings Per Share | 0.84 X | |||
| Price To Earnings To Growth | 1.79 X | |||
| Target Price | 20.0 | |||
| Number Of Employees | 1.86 K | |||
| Beta | 0.57 | |||
| Market Capitalization | 599.81 M | |||
| Total Asset | 931.7 M | |||
| Z Score | 1.6 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 1.48 % | |||
| Net Asset | 931.7 M | |||
| Last Dividend Paid | 0.48 |
About Phibro Animal Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Phibro Animal Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Phibro Animal using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Phibro Animal Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Additional Information and Resources on Investing in Phibro Stock
When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.